Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Breast Cancer

Get Email Updates

Resource Centers

Related Checklists

Breast Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

2 Good News Findings in Breast Cancer Research

By Lynette Summerill HERWriter
 
Rate This
2 Good News Findings in Breast Cancer Research 3 5 10
2 good findings from breast cancer research
Arina Zaiachin/PhotoSpin

It’s no secret the biggest risk factor for breast cancer is being female.

For every eight women in the United States, one will be diagnosed with breast cancer during her lifetime. That statistic means breast cancer is the most common type of cancer among women after some skin cancer types.

In fact, breast cancer is so prevalent in modern society it’s likely you personally know someone who has been recently diagnosed with it, survived it, or died from it.

Today there are two new, potentially good news findings in breast cancer research. One involves the way breast cancer is diagnosed. The other offers insight into preventing it.

’A Better Diagnostic Tool’

Most breast cancer is found using X-ray mammography. It’s currently the only accepted routine screening method for early detection of breast cancer. While it does a pretty good job at catching most breast cancer in its earliest stage, it’s not a perfect test.

Microscopic areas of calcium accumulating inside the breast tissue is typically associated with tumor formation. But a mammogram can’t always accurately distinguish if these “microcalcifications” are harmless noncancerous lesions or the first signal that cancer is present.

Ductal carcinoma in situ (DCIS), a pre-invasive form of breast cancer, is the most common cancer type associated with microcalcifications, states BreastCancer.org.

Ishan Barman, Ph.D., postdoctoral fellow at the Massachusetts Institute of Technology in Cambridge, said that most women with microcalcifications need to undergo a stereotactic core needle biopsy — a procedure where a small amount of breast tissue is retrieved for pathologic analysis — to determine if the microcalcifications are benign or malignant lesions.

But for 15 to 25 percent of women, the biopsies deliver a false-negative (non-conclusive or wrong) result, requiring them to undergo more invasive testing, often a surgical biopsy, according to Barman.

Barman and his colleagues believe that a newly developed, single-step Raman spectroscopy algorithm applied during the core biopsy shows potential in accurately detecting and diagnosing microcalcifications in real-time.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1726 Health

Changed

648 Lives

Saved

512 Lives
2 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Have you been tested for BRCA gene mutation?:
View Results